Intermediate for Venetoclax. Venetoclax (trade name Venclexta) is a small molecule oral drug that treats chronic lymphocytic leukemia (CLL) in those with a specific chromosomal abnormality. Venetoclax is a BH3-mimetic and acts as a Bcl-2 inhibitor. Venetoclax has been approved by US FDA om April 11, 2016.


Product Name:                  1H-Pyrrolo[2,3-b]pyridin-5-ol

Synonyms:                         N/A

CAS Number:                     98549-88-3

Molecular Weight:            134.1372

Molecular Formula:          C7H6N2O

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Oc1cnc2c(c1)cc[nH]2


  • $221.00
  • Ex Tax: $221.00

Available Options